title: A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
abstract: Although meningococcal disease caused by serogroup B remains an important public health concern, a licensed vaccine providing broad protection against this pathogen is not yet available. Advances in genomics have paved the way for the discovery of new vaccine candidates for inclusion into a multicomponent serogroup B vaccine. In this article, we will review recent advances in the development of these vaccines, focussing particularly on one of the 'next generation' MenB vaccines, 4CMenB.
authors: Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia.
authors: Ee Lyn
authors: EL
authors: Su
authors: Matthew D
authors: MD
authors: Snape